Analysts Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $109.00

U.S. Physical Therapy, Inc. (NYSE:USPH) has earned a consensus recommendation of “Buy” from the six brokerages that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $109.00.

A number of equities analysts have weighed in on the company. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Thursday, May 8th. Barrington Research reduced their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. JPMorgan Chase & Co. dropped their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 19th. William Blair reaffirmed a “market perform” rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd.

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. 2.00% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. HighTower Advisors LLC grew its holdings in shares of U.S. Physical Therapy by 2.5% during the 4th quarter. HighTower Advisors LLC now owns 4,833 shares of the company’s stock worth $429,000 after purchasing an additional 119 shares in the last quarter. CBIZ Investment Advisory Services LLC lifted its position in U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock worth $29,000 after purchasing an additional 122 shares during the period. Albert D Mason Inc. grew its stake in U.S. Physical Therapy by 1.3% during the fourth quarter. Albert D Mason Inc. now owns 10,596 shares of the company’s stock worth $940,000 after buying an additional 139 shares in the last quarter. Portside Wealth Group LLC increased its holdings in U.S. Physical Therapy by 3.9% in the 1st quarter. Portside Wealth Group LLC now owns 4,108 shares of the company’s stock valued at $297,000 after buying an additional 154 shares during the period. Finally, Precision Wealth Strategies LLC raised its position in shares of U.S. Physical Therapy by 6.6% in the 1st quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company’s stock valued at $221,000 after buying an additional 189 shares in the last quarter.

U.S. Physical Therapy Price Performance

Shares of USPH opened at $79.81 on Friday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The company’s fifty day simple moving average is $71.89 and its 200 day simple moving average is $83.56. U.S. Physical Therapy has a 1-year low of $62.77 and a 1-year high of $107.09. The company has a market cap of $1.21 billion, a price-to-earnings ratio of 84.90, a PEG ratio of 3.54 and a beta of 1.44.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.02. The company had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The company’s quarterly revenue was up 18.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.51 EPS. On average, research analysts forecast that U.S. Physical Therapy will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be given a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.26%. The ex-dividend date is Friday, May 23rd. U.S. Physical Therapy’s payout ratio is 82.57%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.